Inflection Point Acquisition Corp V(IPEX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.02 | Insider Own | 36.38% | Shs Outstand | 10.9M | Perf Week | -22% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 2.8M | Perf Month | -18.81% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | 0.1 | Inst Own | - | Short Float | 0.08% | Perf Quarter | -18.13% |
| Income | -0.00B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.07 | Perf Half Y | -17.22% |
| Sales | 0.00B | P/B | 1.22 | EPS next 5Y | - | ROA | -0.28% | Short Interest | 0.00M | Perf YTD | -16.54% |
| Book/sh | 7.05 | P/C | 634 | EPS past 3/5Y | - | ROE | -0.29% | 52W High | -27.93% ($11.90) | Perf Year | -15.72% |
| Cash/sh | 0.01 | P/FCF | - | Sales past 3/5Y | - | ROIC | -0.29% | 52W Low | 43% ($6.00) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -126.35% | Gross Margin | - | Volatility(W/M) | 25.25% 6.4% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.66 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.05 | EPS Q/Q | -48.01% | Profit Margin | - | RSI (14) | 33.9 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.05 | Sales Q/Q | - | SMA20 | -15.92% ($10.2) | Beta | 0.18 | Target Price | $14 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/09/02 | SMA50 | -17.46% ($10.39) | Rel Volume | 7.07 | Prev Close | $9.18 |
| Employees | - | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | - | SMA200 | -17.23% ($10.37) | Avg Volume(3M) | 0.03M | Price | $8.58 |
| IPO | 2025/3/7 | Option/Short | No/Yes | Trades | 1257 | Volume | 236,846 | Change | -6.54% |
Company
IPEX is a Financial sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🚀 A special purpose acquisition company (SPAC) incorporated in the Cayman Islands, pursuing a merger with a promising business sector using the proceeds from its IPO held in an escrow account. The structure is designed to identify and prepare a merger target in the genetic services space through its sponsor network, with the goal of completing a transition to a listed operating company.
Over the past 1 year, roughly in the middle
28% below its 1-year high.
IPEX has weak earning power
Review management risk carefully before investing
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Generally in line with estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Long-term returns are close to the market
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 36.4%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
RNMN 0.00%
SPCZ 0.00%It ranks #4 in the industry
Based on market cap of $38M.
IPEX $38M PER -
LION $3B PER -
BBCQ $2B PER -
CCXI $714M PER -
FAQ
What kind of company is IPEX?
IPEX belongs to the Financial sector and operates in the Shell Companies industry.
What is the market cap of IPEX?
The market cap of IPEX is approximately $38M, ranking 5,053 within its sector.
What is the 52-week high and low for IPEX?
IPEX has recorded a 52-week high of $11.90 and a low of $6.00.
